Grundläggande statistik
| CIK | 1719395 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Eargo, Inc.
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| February 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-39616 EARGO, INC. (Exact name of registrant as specified in its charter) 26 |
|
| February 21, 2024 |
As filed with the Securities and Exchange Commission on February 21, 2024 As filed with the Securities and Exchange Commission on February 21, 2024 Registration No. |
|
| February 21, 2024 |
As filed with the Securities and Exchange Commission on February 21, 2024 As filed with the Securities and Exchange Commission on February 21, 2024 Registration No. |
|
| February 21, 2024 |
As filed with the Securities and Exchange Commission on February 21, 2024 As filed with the Securities and Exchange Commission on February 21, 2024 Registration No. |
|
| February 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Amendment No. 4) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(E) OF THE SECURITIES EXCHANGE ACT OF 1934 Eargo, Inc. (Name of the Issuer) Eargo, Inc. PSC Echo Parent LLC, PSC Echo Merger Sub Inc., PSC Echo, LP, PSC Echo GP, LLC (Names of Persons Filing Statement) Common Stock, Par Value $0.0001 per share (T |
|
| February 16, 2024 |
EAR / Eargo, Inc. / PSC Echo, LP - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) Eargo, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 270087109 (CUSIP Number) Adam Fliss Founding Partner and General Counsel Patient Square Capital, LP 2884 Sand Hill Road, Suite 100 Menlo Park, C |
|
| February 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2024 EARGO, INC. (Exact name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-39616 (Commission File Number) 27-3879 |
|
| February 16, 2024 |
TENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION EARGO, INC. Exhibit 3.1 EXHIBIT A TENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF EARGO, INC. 1. Name. The name of this corporation is Eargo, Inc. (the “Corporation”). 2. Registered Office. The registered office of the Corporation in the State of Delaware is located at c/o Maples Fiduciary Services (Delaware) Inc., 4001 Kennett Pike, Suite 302, Wilmington, New Castle County, Delaware 19807. The nam |
|
| February 16, 2024 |
Exhibit 99.1 Eargo Announces Closing of Acquisition By Patient Square Capital Eargo Taken Private for $2.55 per Share in Cash SAN JOSE, Calif., February 16, 2024 – Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, announced today the closing of its acquisition by an affiliate of Patient Square Capital (“Patient Square”), a leadin |
|
| February 16, 2024 |
Eargo, Inc. 2665 North First Street, Suite 300 San Jose CA 95134 Eargo, Inc. 2665 North First Street, Suite 300 San Jose CA 95134 February 16, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Eargo, Inc. Request to Withdraw Registration Statement on Form S-1 File No. 333-268859 Ladies and Gentlemen: Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities A |
|
| February 16, 2024 |
AMENDED AND RESTATED BY-LAWS OF EARGO, INC. Section 1. LAW, CERTIFICATE OF INCORPORATION AND BY-LAWS Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF EARGO, INC. Section 1. LAW, CERTIFICATE OF INCORPORATION AND BY-LAWS 1.1. These by-laws are subject to the certificate of incorporation of Eargo, Inc. (the “Corporation”) and any stockholders agreement then in effect to which the Corporation is a party. In these by-laws, references to law, the certificate of incorporation and by-laws mean the law, the pr |
|
| February 14, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2024 EARGO, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39616 27-3879804 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| January 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Amendment No. 3) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(E) OF THE SECURITIES EXCHANGE ACT OF 1934 Eargo, Inc. (Name of the Issuer) Eargo, Inc. PSC Echo Parent LLC, PSC Echo Merger Sub Inc., PSC Echo, LP, PSC Echo GP, LLC (Names of Persons Filing Statement) Common Stock, Par Value $0.0001 per share (T |
|
| January 16, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| January 5, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 2) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| January 5, 2024 |
DRAFT Michael Gilson +1 650 752 2015 [email protected] Davis Polk & Wardwell llp 1600 El Camino Real Menlo Park, CA 94025 davispolk.com January 5, 2024 Re: Eargo, Inc. Schedule 13E-3/A filed December 28, 2023 by PSC Echo, LP et al. File No. 005-91783 Revised Preliminary Proxy Statement filed December 28, 2023 File No. 001-39616 U.S. Securities and Exchange Commission Division of Corpora |
|
| January 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Amendment No. 2) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(E) OF THE SECURITIES EXCHANGE ACT OF 1934 Eargo, Inc. (Name of the Issuer) Eargo, Inc. PSC Echo Parent LLC, PSC Echo Merger Sub Inc., PSC Echo, LP, PSC Echo GP, LLC (Names of Persons Filing Statement) Common Stock, Par Value $0.0001 per share (T |
|
| December 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Amendment No. 1) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(E) OF THE SECURITIES EXCHANGE ACT OF 1934 Eargo, Inc. (Name of the Issuer) Eargo, Inc. PSC Echo Parent LLC, PSC Echo Merger Sub Inc., PSC Echo, LP, PSC Echo GP, LLC (Names of Persons Filing Statement) Common Stock, Par Value $0.0001 per share (T |
|
| December 28, 2023 |
Michael Gilson +1 650 752 2015 [email protected] Davis Polk & Wardwell llp 1600 El Camino Real Menlo Park, CA 94025 davispolk.com December 28, 2023 Re: Eargo, Inc. Schedule 13E-3 filed November 21, 2023 by PSC Echo, LP et al. File No. 005-91783 Preliminary Proxy Statement filed November 21, 2023 File No. 001-39616 U.S. Securities and Exchange Commission Division of Corporation Finance O |
|
| December 28, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| December 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2023 EARGO, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39616 27-3879804 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| December 22, 2023 |
Exhibit 10.1 December 20, 2023 Mark Thorpe (sent via DocuSign) Dear Mark: On behalf of Eargo, Inc., (the “Company”), and following the approval of the Company’s Board of Directors, we are pleased to offer you a new position within the Company as Chief Financial Officer (CFO), effective January 5, 2024. The details and terms associated with the new position are listed below: Job Title: Chief Financ |
|
| December 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| November 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(E) OF THE SECURITIES EXCHANGE ACT OF 1934 Eargo, Inc. (Name of the Issuer) Eargo, Inc. PSC Echo Parent LLC, PSC Echo Merger Sub Inc., PSC Echo, LP, PSC Echo GP, LLC (Names of Persons Filing Statement) Common Stock, Par Value $0.0001 per share (Title of Class of S |
|
| November 21, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| November 21, 2023 |
Exhibit (c)(ii) Project Puma: Discussion Materials October 19, 2023 2 Topics for Discussion Situation Overview What Are Puma’s Potential Strategic Alternatives? Preliminary Puma Financial Analysis Based on Management Projections Process Considerations & Next Steps Situation Overview and Assessment of Strategic Alternatives 4 Situation Overview In May 2021, Puma disclosed a claims audit by an insur |
|
| November 21, 2023 |
Exhibit (c)(iii) Project Puma: Discussion Materials October 28, 2023 2 Overview of Patient Square Capital’s Indication of Interest Valuation & Consideration Patient Square Capital (PSC) has offered to acquire the Company for cash consideration of $2. |
|
| November 21, 2023 |
Exhibit (c)(iv) Project Puma: Discussion Materials October 29, 2023 2 Overview of Patient Square Capital’s Offer and Key Merger Agreement Terms Valuation & Consideration Patient Square Capital (PSC) has offered to acquire the Company for cash consideration of $2. |
|
| November 21, 2023 |
Eargo, Inc. Table 1: Transaction Valuation Exhibit 107 Eargo, Inc. Table 1: Transaction Valuation Proposed Maximum Aggregate Value of Transaction Fee Rate Amount of Filing Fee Fees to be Paid $ 12,808,583.70 (1) 0.00014760 $ 1,890.55 (2) Fees Previously Paid $ 0 $ 0 Total Transaction Valuation $ 53,152,896.15 Total Fees Due for Filing $ 1,890.55 Total Fees Previously Paid $ 0 Total Fee Offsets $ 0 Net Fee Due $ 1,890.55 (1) Aggregate numbe |
|
| November 21, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Schedule 13E-3 (Form Type) Eargo, Inc. |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39616 Eargo, Inc. |
|
| October 30, 2023 |
Exhibit 99.1 Eargo To Be Taken Private By Patient Square Capital Eargo Shareholders to Receive $2.55 per Share in Cash, Representing a 52% Premium Over Eargo’s Latest Closing Share Price SAN JOSE, Calif., October 30, 2023 – Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, announced today that it has entered into a definitive mer |
|
| October 30, 2023 |
Exhibit 2.1 EXECUTION VERSION CONFIDENTIAL AGREEMENT AND PLAN OF MERGER by and among PSC ECHO Parent LLC, PSC ECHO MERGER SUB INC. and Eargo, INC. Dated as of October 29, 2023 TABLE OF CONTENTS ARTICLE 1 THE MERGER; CLOSING; EFFECTIVE TIME 6 Section 1.01. The Merger 6 Section 1.02. Closing 6 Section 1.03. Effective Time 7 ARTICLE 2 CERTIFICATE OF INCORPORATION AND BYLAWS OF THE SURVIVING CORPORATI |
|
| October 30, 2023 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware No. 001-39616 27-3879804 (State or other jurisdiction of incorporation or organization) (C |
|
| October 30, 2023 |
Exhibit 2.2 Execution Version Privileged & Confidential VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”) dated as of October 29, 2023 is entered into by and between Eargo, Inc., a Delaware corporation (the “Company”) and PSC Echo, LP, a Delaware limited partnership (the “PSC Stockholder”). WHEREAS, the board of directors of the Company (the “Company Board”) establi |
|
| October 30, 2023 |
EAR / Eargo Inc / PSC Echo, LP - SC 13D/A Activist Investment SC 13D/A 1 d557911dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Eargo, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 270087109 (CUSIP Number) Adam Fliss Founding Partner and General Counsel Patient Square Capital, LP 2884 Sand Hill |
|
| October 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware No. 001-39616 27-3879804 (State or other jurisdiction of incorporation or organization) (C |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39616 Eargo, Inc. |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number |
|
| August 10, 2023 |
Eargo Reports Second Quarter 2023 Financial Results Exhibit 99.1 Eargo Reports Second Quarter 2023 Financial Results Recent Highlights: • Net revenues of $8.1 million in the second quarter of 2023, up 12% year-over-year • Gross systems shipped of 5,098, up 14 % year-over-year • GAAP total operating loss $25.8 million in the second quarter of 2023, compared to $31.4 million in the second quarter of 2022 • In connection with the implementation of the |
|
| August 10, 2023 |
Exhibit 10.2 June 23, 2023 By Electronic Delivery Christian Gormsen Dear Mr. Gormsen: As we have discussed, your employment with Eargo, Inc., a Delaware corporation (the “Company”) will terminate, by reason of your voluntary resignation, effective as of June 30, 2023 (the “Separation Date”). The purpose of this letter (the “Agreement”) is to confirm the terms concerning your separation from employ |
|
| June 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2022 EARGO, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39616 27-3879804 (State or Other Jurisdiction of Incorporation) (C |
|
| June 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 07, 2023 EARGO, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39616 27-3879804 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 30, 2023 |
CONFLICT MINERALS REPORT EARGO, INC. Exhibit 1.01 CONFLICT MINERALS REPORT EARGO, INC. This Conflict Minerals Report (“CMR”) has been prepared by Eargo, Inc. (herein referred to, collectively with its consolidated subsidiaries, alternatively, as “Eargo,” “we,” “our” and “us”). This CMR for the reporting period January 1, 2022 to December 31, 2022 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as ame |
|
| May 30, 2023 |
SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Eargo, Inc. (Exact name of the registrant as specified in its charter) Delaware 001-39616 (State or other jurisdiction of incorporation) (Commission file number) 2665 North First Street, Suite 300 San Jose, California 95134 (Address of principal executive offices) (Zip code) Christy La |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 11, 2023 |
Non-Employee Director Compensation Program, as amended through April 20, 2023.#† Exhibit 10.3 EARGO, INC. Non-Employee DIRECTOR COMPENSATION PROGRAM (as amended through April 20, 2023) Non-employee members of the board of directors (the “Board”) of Eargo, Inc. (the “Company”) shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this “Program”) effective as of October 15, 2020 (the “Effective Date”). The cash |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39616 Eargo, Inc. |
|
| May 11, 2023 |
Eargo Reports First Quarter 2023 Financial Results EX-99.1 Exhibit 99.1 Eargo Reports First Quarter 2023 Financial Results Recent Highlights: • Net revenues of $11.8 million in the first quarter of 2023, up 29% year-over-year • Gross systems shipped of 8,705, up 51% year-over-year • GAAP total operating loss $22.8 million in the first quarter of 2023, compared to $30.4 million in the first quarter of 2022 • Commercially launched Eargo 7, a self-fi |
|
| April 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| April 24, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| March 23, 2023 |
Eargo, Inc. 2020 Incentive Award Plan. Exhibit 99.1(a) EARGO, INC. 2020 INCENTIVE AWARD PLAN (as amended through February 1, 2023) ARTICLE I. PURPOSE The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. ARTICLE II. DEFINITIONS As used in the Plan, the fol |
|
| March 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| March 23, 2023 |
Exhibit 4.3 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2022, Eargo, Inc. had common stock, $0.0001 par value per share, registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and listed on the Nasdaq Global Select Market under the trading symbol “EAR.” DESCRIPTION O |
|
| March 23, 2023 |
As filed with the Securities and Exchange Commission on March 23, 2023 As filed with the Securities and Exchange Commission on March 23, 2023 Registration No. |
|
| March 23, 2023 |
2020 Incentive Award Plan, as amended through February 1, 2023.# Exhibit 10.3(a) Eargo, Inc. 2020 INCENTIVE AWARD PLAN (as amended through February 1, 2023) ARTICLE I. Purpose The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. ARTICLE II. Definitions As used in the Plan, the fol |
|
| March 23, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Eargo, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1—Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount to be Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock, $0.0001 par valu |
|
| March 23, 2023 |
Eargo, Inc. 2020 Employee Stock Purchase Plan. Exhibit 99.2 EARGO, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN ARTICLE 1 PURPOSE The Plan’s purpose is to assist employees of the Company and its Designated Subsidiaries in acquiring a stock ownership interest in the Company, and to help such employees provide for their future security and to encourage them to remain in the employment of the Company and its Subsidiaries. The Plan consists of two compo |
|
| March 23, 2023 |
Employment Agreement by and between Eargo, Inc. and Mark Thorpe. Exhibit 10.9 EARGO, INC. EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”), entered into effective as of January 16, 2022 (the “Effective Date”), is between Eargo, Inc., a Delaware corporation (the “Company”) and Mark Thorpe (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Compa |
|
| March 23, 2023 |
Eargo Reports Fourth Quarter 2022 Financial Results EX-99.1 Exhibit 99.1 Eargo Reports Fourth Quarter 2022 Financial Results Recent Highlights: • Net revenues of $12.9 million in the fourth quarter of 2022, compared to $10.1 million in the fourth quarter of 2021 and $7.9 million in the third quarter of 2022 • Gross systems shipped of 8,863, compared to 7,767 in the fourth quarter of 2021 • GAAP operating loss $23.9 million in the fourth quarter of |
|
| March 23, 2023 |
Exhibit 21.1 Subsidiaries of Eargo, Inc. The registrant’s subsidiaries and affiliates as of December 31, 2022 are included in the list below. Legal Name of Subsidiary Jurisdiction of Organization Eargo Hearing, Inc. California Eargo Screening, LLC Delaware |
|
| March 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39616 Eargo, Inc. (Ex |
|
| March 23, 2023 |
2020 Employee Stock Purchase Plan.# Exhibit 10.4 EARGO, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN ARTICLE 1 PURPOSE The Plan’s purpose is to assist employees of the Company and its Designated Subsidiaries in acquiring a stock ownership interest in the Company, and to help such employees provide for their future security and to encourage them to remain in the employment of the Company and its Subsidiaries. The Plan consists of two compo |
|
| February 13, 2023 |
424B3 1 d463402d424b3.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-268859 Prospectus Supplement No. 1 (To Prospectus dated February 13, 2023) Eargo, Inc. This prospectus supplement updates, amends and supplements the prospectus dated February 13, 2023 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-268859). Capital |
|
| February 13, 2023 |
Up to 15,821,299 Shares of Common Stock Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-268859 Prospectus Up to 15,821,299 Shares of Common Stock This prospectus relates to the resale of up to 15,821,299 shares of our common stock by the Selling Stockholder named in this prospectus or its permitted transferees. We are registering the shares for resale pursuant to such stockholder’s registration rights under a reg |
|
| February 9, 2023 |
Eargo, Inc. 2665 North First Street, Suite 300 San Jose, California 95134 CORRESP 1 filename1.htm Eargo, Inc. 2665 North First Street, Suite 300 San Jose, California 95134 February 9, 2023 VIA EDGAR AND E-MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Margaret Schwartz; Celeste Murphy Re: Eargo, Inc. Registration Statement on Form S-1 File No. 333-268859 To the addressees se |
|
| February 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| February 6, 2023 |
Nasdaq Confirms Eargo’s Minimum Bid Price Deficiency is Cured Exhibit 99.1 Nasdaq Confirms Eargo’s Minimum Bid Price Deficiency is Cured SAN JOSE, Calif., Feb. 6, 2023 (GLOBE NEWSWIRE) - Eargo, Inc. (Nasdaq: EAR) (the “Company” or Eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, announced today that it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) dated February 1, 2023 informing Eargo |
|
| January 30, 2023 |
As filed with the U.S. Securities and Exchange Commission on January 30, 2023 S-1/A Table of Contents As filed with the U.S. Securities and Exchange Commission on January 30, 2023 Registration No. 333-268859 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Eargo, Inc. (Exact name of registrant as specified in its charter) Delaware 5047 27-3879804 (State or other jurisd |
|
| January 30, 2023 |
EX-FILING FEES Calculation of Filing Fee Table Form S-1 (Form Type) Eargo, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equit |
|
| January 30, 2023 |
CORRESP 1 filename1.htm 140 Scott Drive Menlo Park, California 94025 Tel: +1.650.328.4600 Fax: +1.650.463.2600 www.lw.com FIRM / AFFILIATE OFFICES Austin Milan Beijing Munich Boston New York Brussels Orange County Century City Paris Chicago Riyadh Dubai San Diego Düsseldorf San Francisco Frankfurt Seoul Hamburg Shanghai Hong Kong Silicon Valley Houston Singapore London Tel Aviv Los Angeles Tokyo M |
|
| January 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| January 17, 2023 |
Second Certificate of Amendment to Amended and Restated Certificate of Incorporation. EX-3.1 2 brhc10046632ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF EARGO, INC. Eargo, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the Delaware General Corporation Law, hereby certifies as follows: (a) The name of the Corporation is Eargo, Inc. and the date on which the original Certificat |
|
| January 17, 2023 |
Eargo Effects 1-for-20 Reverse Stock Split Exhibit 99.1 Eargo Effects 1-for-20 Reverse Stock Split SAN JOSE, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) – Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced that it has filed a Certificate of Amendment (the “Amendment”) to its Amended and Restated Certificate of Incorporation with |
|
| January 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| January 13, 2023 |
Office Lease, dated January 11, 2023, by and between Eargo, Inc. and Nashland TT, LP. Exhibit 10.1 OFFICE LEASE BETWEEN NASHLAND TT, LP AS LANDLORD AND EARGO, INC. AS TENANT FOR HIGHLAND RIDGE I SUMMARY OF BASIC LEASE INFORMATION This Summary of Basic Lease Information (the “Lease Summary”) is hereby incorporated into and made a part of the attached Lease (this Lease Summary and the Lease to be known collectively as the “Lease”). In the event of a conflict between the terms of this |
|
| January 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| January 11, 2023 |
Eargo to Complete a 1-for-20 Reverse Stock Split EX-99.1 2 brhc10046460ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Eargo to Complete a 1-for-20 Reverse Stock Split SAN JOSE, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) – Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced that its Board of Directors has approved a 1-for-20 reverse stock split |
|
| January 4, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2023 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number |
|
| January 4, 2023 |
HEARING WELLNESS PIONEER EARGO LAUNCHES EARGO 7, ITS MOST REVOLUTIONARY DEVICE YET, AT CES Exhibit 99.1 HEARING WELLNESS PIONEER EARGO LAUNCHES EARGO 7, ITS MOST REVOLUTIONARY DEVICE YET, AT CES ? EARGO 7 OFFERS CLARITY MODE, CREATING ITS MOST NATURAL HEARING EXPERIENCE FOR THOSE WITH MILD TO MODERATE HEARING LOSS ? NEW OTC DEVICE TO BE AVAILABLE IN-STORE THROUGH PARTNERSHIP WITH VICTRA, ONE OF AMERICA?S LARGEST WIRELESS RETAILERS ? EARGO 5 AND 6 HAVE RECEIVED FDA 510(K) CLEARANCE AS SE |
|
| December 19, 2022 |
As filed with the U.S. Securities and Exchange Commission on December 16, 2022 S-1 Table of Contents As filed with the U.S. Securities and Exchange Commission on December 16, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Eargo, Inc. (Exact name of registrant as specified in its charter) Delaware 5047 27-3879804 (State or other jurisdiction of incorporation or |
|
| December 19, 2022 |
EX-FILING FEES Calculation of Filing Fee Table Form S-1 (Form Type) Eargo, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equit |
|
| December 16, 2022 |
EAR / Eargo Inc / Nan Fung Group Holdings Ltd - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Rule 13d-101) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. |
|
| December 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| December 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 23, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) ( |
|
| December 12, 2022 |
Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Eargo, Inc. (Name of Issuer) Common Stock, $.0001 par value (Title of Class of Securities) 270087109 (CUSIP Number) Louis S. Citron, Esq. New Enterprise Associates 1954 Greenspring Drive, Suite 600, Timonium, MD 21093 (410) 842-4000 (Name, A |
|
| December 12, 2022 |
Exhibit 99.1 EARGO ANNOUNCES CLOSING OF RIGHTS OFFERING AND CONVERSION OF PATIENT SQUARE NOTES INTO SHARES OF EARGO COMMON STOCK SAN JOSE, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) – Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, announced today the closing and final results of its rights offerin |
|
| December 12, 2022 |
Eargo, Inc. Welcomes Patient Square Capital As New Majority Owner Following Rights Offering Exhibit 99.2 Eargo, Inc. Welcomes Patient Square Capital As New Majority Owner Following Rights Offering SAN JOSE, Calif., Nov 29, 2022 – Eargo, Inc. (Nasdaq: EAR) (“Eargo” or “the Company”), a medical device company on a mission to improve the quality of life of people with hearing loss, is pleased to announce today that Patient Square Capital (“Patient Square”) has become the majority equity own |
|
| December 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| December 7, 2022 |
Exhibit 99.1 Eargo Announces Strategic Additions to Board of Directors Following Patient Square Capital Becoming New Majority Shareholder SAN JOSE, Calif., December 7, 2022 – Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the appointments of several new directors following the |
|
| December 7, 2022 |
EAR / Eargo Inc / PSC Echo, LP - SC 13D/A Activist Investment SC 13D/A 1 d362507dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Eargo, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 270087109 (CUSIP Number) Adam Fliss Founding Partner and General Counsel Patient Square Capital, LP 2884 Sand Hill |
|
| December 5, 2022 |
EAR / Eargo Inc / PSC Echo, LP - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Eargo, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 270087109 (CUSIP Number) Adam Fliss Founding Partner and General Counsel Patient Square Capital, LP 2884 Sand Hill Road, Suite 100 Menlo Park, CA 94025 (650) 384-6558 (Nam |
|
| December 5, 2022 |
Exhibit 99.1 Joint Filing Agreement The undersigned hereby agree to the joint filing on behalf of each of them of the Statement on Schedule 13D with respect to the Common Stock of Eargo, Inc., and any further amendments to such statement on Schedule 13D executed by each of them pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. |
|
| November 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 23, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| November 29, 2022 |
Eargo, Inc. Welcomes Patient Square Capital As New Majority Owner Following Rights Offering Exhibit 99.2 Eargo, Inc. Welcomes Patient Square Capital As New Majority Owner Following Rights Offering SAN JOSE, Calif., Nov 29, 2022 – Eargo, Inc. (Nasdaq: EAR) (“Eargo” or “the Company”), a medical device company on a mission to improve the quality of life of people with hearing loss, is pleased to announce today that Patient Square Capital (“Patient Square”) has become the majority equity own |
|
| November 29, 2022 |
Exhibit 99.1 EARGO ANNOUNCES CLOSING OF RIGHTS OFFERING AND CONVERSION OF PATIENT SQUARE NOTES INTO SHARES OF EARGO COMMON STOCK SAN JOSE, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) – Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, announced today the closing and final results of its rights offerin |
|
| November 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| November 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| November 16, 2022 |
FWP 1 brhc10044288fwp.htm FWP Free Writing Prospectus Dated November 16, 2022 Filed Pursuant to Rule 433 Registration No. 333-267071 On November 16, 2022, Eargo, Inc. (“Eargo” or the “Company”) issued a press release reminding stockholders of various important deadlines relating to the Company’s previously announced rights offering. Certain information linked within this communication have been pr |
|
| November 14, 2022 |
IMPORTANT REMINDER FOR EARGO STOCKHOLDERS OF RECORD AS OF OCTOBER 24, 2022: Free Writing Prospectus Dated November 14, 2022 Filed Pursuant to Rule 433 Registration No. |
|
| November 8, 2022 |
IMPORTANT REMINDER FOR EARGO STOCKHOLDERS OF RECORD AS OF OCTOBER 24, 2022: Free Writing Prospectus Dated November 8, 2022 Filed Pursuant to Rule 433 Registration No. |
|
| November 7, 2022 |
Free Writing Prospectus Dated November 7, 2022 Filed Pursuant to Rule 433 Registration No. |
|
| November 7, 2022 |
Exhibit 99.1 Capitalization The following table sets forth our cash and cash equivalents and our capitalization as of September 30, 2022 on: • an actual basis; and • a pro forma basis, to give effect to (a) the approval by our stockholders at the 2022 Annual Meeting to increase the number of authorized shares of common stock under our amended and restated articles of incorporation to 450,000,000, |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39616 Eargo, Inc. |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| November 3, 2022 |
Exhibit 99.2 Eargo Now Available for Purchase in ~1,500 Victra Wireless Stores Nationwide Eargo Announces Partnership with Victra, one of America’s Largest Wireless Retailers, for In-Person Retail Experience Across the Country SAN JOSE, Calif., November 3, 2022 – Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today anno |
|
| November 3, 2022 |
Eargo Reports Third Quarter 2022 Financial Results Exhibit 99.1 Eargo Reports Third Quarter 2022 Financial Results Third Quarter 2022 Highlights: • Net revenues of $7.9 million, compared to ($22.9) million in the prior year period • Gross systems shipped of 5,156, compared to 13,117 in the prior year period • Return accrual rate of 32.3%, compared to 46.4% in the prior year period • GAAP gross margin of 24.0%; non-GAAP gross margin of 24.5% • GAAP |
|
| October 31, 2022 |
Free Writing Prospectus Dated October 31, 2022 Filed Pursuant to Rule 433 Registration No. |
|
| October 28, 2022 |
Rights to Purchase Up to 375,000,000 Shares of Common Stock 424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-267071 Prospectus Rights to Purchase Up to 375,000,000 Shares of Common Stock We are distributing to the holders (collectively, the “stockholders”) of our common stock, par value $0.0001 per share (the “common stock”) non-transferable rights (the “rights”) to purchase up to an aggregate of 375,000,000 shares of our commo |
|
| October 26, 2022 |
Form of Letter to Stockholders who are Record Holders EX-99.2 Exhibit 99.2 FORM OF LETTER TO STOCKHOLDERS WHO ARE RECORD HOLDERS OF EARGO, INC. Subscription Rights to Purchase Shares Offered Pursuant to Subscription Rights Distributed to Stockholders of Eargo, Inc. , 2022 Dear Stockholder: This letter is being distributed by Eargo, Inc., a Delaware corporation (the “Company”) to all holders of record of shares of its common stock, $0.0001 par value p |
|
| October 26, 2022 |
Form of Instructions as to Use of Eargo, Inc.’s Rights Certificates EX-99.1 Exhibit 99.1 FORM OF INSTRUCTIONS AS TO USE OF EARGO, INC.’S RIGHTS CERTIFICATE Please consult Morrow Sodali LLC as to any questions at (800) 662-5200 and via email at [email protected]. The following instructions relate to a rights offering (the “Rights Offering”) by Eargo, Inc., a Delaware corporation (“Eargo”), to the holders of record of its common stock, $0.0001 par v |
|
| October 26, 2022 |
Form of Letter to Beneficial Holders EX-99.4 Exhibit 99.4 FORM OF LETTER TO STOCKHOLDERS WHO ARE BENEFICIAL OWNERS EARGO, INC. Subscription Rights to Purchase Shares of Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of Eargo, Inc. , 2022 Dear Stockholder: This letter is being distributed by Eargo, Inc., a Delaware corporation (the “Company”) to all holders (“Beneficial Owners”) of shares of its commo |
|
| October 26, 2022 |
As filed with the U.S. Securities and Exchange Commission on October 25, 2022 S-1/A Table of Contents As filed with the U.S. Securities and Exchange Commission on October 25, 2022 Registration No. 333-267071 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Eargo, Inc. (Exact name of registrant as specified in its charter) Delaware 5047 27-3879805 (State or other jurisd |
|
| October 26, 2022 |
Form of Letter to Brokers, Dealers, Banks and Other Nominees EX-99.3 Exhibit 99.3 FORM OF LETTER TO BROKERS, DEALERS, BANKS AND OTHER NOMINEES EARGO, INC. Subscription Rights to Purchase Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of Eargo, Inc. , 2022 To Brokers, Dealers, Banks and Other Nominees: This letter is being distributed by Eargo, Inc., a Delaware corporation (the “Company”) to brokers, dealers, banks and other |
|
| October 26, 2022 |
EX-4.3 Exhibit 4.3 CERTIFICATE # NUMBER OF SUBSCRIPTION RIGHTS: THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANY’S PROSPECTUS DATED , 2022 (THE “PROSPECTUS”) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF THE PROSPECTUS ARE AVAILABLE AT THE SECURITIES AND EXCHANGE COMMISSION’S WEBSITE AT WWW.SEC.GOV AND UPON REQUEST FROM MORROW SODALI LLC, AS INFORMATION AGENT. EAR |
|
| October 26, 2022 |
Form of Broker Letter to Clients who are Beneficial Holders EX-99.5 Exhibit 99.5 FORM OF BROKER LETTER TO CLIENTS WHO ARE BENEFICIAL OWNERS EARGO, INC. Subscription Rights to Purchase Shares of Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of Eargo, Inc. , 2022 To our Clients: This letter is being distributed to our clients who are holders of Eargo, Inc., a Delaware corporation (the “Company”) common stock, $0.0001 par va |
|
| October 25, 2022 |
EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Eargo, Inc. |
|
| October 25, 2022 |
Form of Broker Letter to Clients who are Beneficial Holders EX-99.5 Exhibit 99.5 FORM OF BROKER LETTER TO CLIENTS WHO ARE BENEFICIAL OWNERS EARGO, INC. Subscription Rights to Purchase Shares of Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of Eargo, Inc. , 2022 To our Clients: This letter is being distributed to our clients who are holders of Eargo, Inc., a Delaware corporation (the “Company”) common stock, $0.0001 par va |
|
| October 25, 2022 |
Form of Letter to Brokers, Dealers, Banks and Other Nominees EX-99.3 Exhibit 99.3 FORM OF LETTER TO BROKERS, DEALERS, BANKS AND OTHER NOMINEES EARGO, INC. Subscription Rights to Purchase Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of Eargo, Inc. , 2022 To Brokers, Dealers, Banks and Other Nominees: This letter is being distributed by Eargo, Inc., a Delaware corporation (the “Company”) to brokers, dealers, banks and other |
|
| October 25, 2022 |
EX-4.3 Exhibit 4.3 CERTIFICATE # NUMBER OF SUBSCRIPTION RIGHTS: THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANY’S PROSPECTUS DATED , 2022 (THE “PROSPECTUS”) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF THE PROSPECTUS ARE AVAILABLE AT THE SECURITIES AND EXCHANGE COMMISSION’S WEBSITE AT WWW.SEC.GOV AND UPON REQUEST FROM MORROW SODALI LLC, AS INFORMATION AGENT. EAR |
|
| October 25, 2022 |
Eargo, Inc. 2665 North First Street, Suite 300 San Jose, California 95134 Eargo, Inc. 2665 North First Street, Suite 300 San Jose, California 95134 October 25, 2022 VIA EDGAR AND E-MAIL United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Christine Westbrook Re: Eargo, Inc. Registration Statement on Form S-1 File No. 333-267071 Ladies and Gentlemen: In accordanc |
|
| October 25, 2022 |
Form of Notice of Guaranteed Delivery EX-99.9 Exhibit 99.9 FORM OF NOTICE OF GUARANTEED DELIVERY FOR SUBSCRIPTION RIGHTS ISSUED BY EARGO, INC. This form, or one substantially equivalent hereto, must be used to exercise subscription rights (the “Subscription Rights”) pursuant to the rights offering (the “Rights Offering”) described in the prospectus, dated , 2022 (the “Prospectus”), of Eargo, Inc., a Delaware corporation (“Eargo”), if |
|
| October 25, 2022 |
As filed with the U.S. Securities and Exchange Commission on October 25, 2022 S-1/A Table of Contents As filed with the U.S. Securities and Exchange Commission on October 25, 2022 Registration No. 333-267071 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Eargo, Inc. (Exact name of registrant as specified in its charter) Delaware 5047 27-3879805 (State or other jurisd |
|
| October 25, 2022 |
Form of Beneficial Owner Election Form EX-99.6 Exhibit 99.6 FORM OF BENEFICIAL OWNER ELECTION FORM EARGO, INC. The undersigned acknowledge(s) receipt of your letter and the enclosed materials referred to therein relating to the rights offering (the “Rights Offering”) by Eargo, Inc., a Delaware corporation (the “Company”), of subscription rights (the “Subscription Rights”) to purchase shares of the Company’s common stock, $0.0001 par va |
|
| October 25, 2022 |
Form of Letter to Stockholders who are Record Holders EX-99.2 Exhibit 99.2 FORM OF LETTER TO STOCKHOLDERS WHO ARE RECORD HOLDERS OF EARGO, INC. Subscription Rights to Purchase Shares Offered Pursuant to Subscription Rights Distributed to Stockholders of Eargo, Inc. , 2022 Dear Stockholder: This letter is being distributed by Eargo, Inc., a Delaware corporation (the “Company”) to all holders of record of shares of its common stock, $0.0001 par value p |
|
| October 25, 2022 |
Form of Letter to Beneficial Holders EX-99.4 Exhibit 99.4 FORM OF LETTER TO STOCKHOLDERS WHO ARE BENEFICIAL OWNERS EARGO, INC. Subscription Rights to Purchase Shares of Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of Eargo, Inc. , 2022 Dear Stockholder: This letter is being distributed by Eargo, Inc., a Delaware corporation (the “Company”) to all holders (“Beneficial Owners”) of shares of its commo |
|
| October 25, 2022 |
Form of Nominee Holder Certification EX-99.7 Exhibit 99.7 FORM OF NOMINEE HOLDER CERTIFICATION EARGO, INC. The undersigned, a bank, broker, dealer, trustee, depositary, or other nominee of subscription rights (the “Subscription Rights”) to purchase shares of common stock of Eargo, Inc., a Delaware corporation (the “Company”), pursuant to the Rights Offering described and provided for in the Company’s prospectus dated , 2022, (the “Pr |
|
| October 25, 2022 |
Form of Notice of Important Tax Information EX-99.8 Exhibit 99.8 FORM OF NOTICE OF IMPORTANT TAX INFORMATION EARGO, INC. This notice is provided in connection with the prospectus of EARGO, INC. (the “Company”), dated , 2022. Under the U.S. federal income tax laws, dividends (including constructive dividends) that may be paid by the Company in respect of the shares of common stock (“Common Stock”) acquired through the exercise of the rights |
|
| October 25, 2022 |
Form of Instructions as to Use of Eargo, Inc.’s Rights Certificates EX-99.1 Exhibit 99.1 FORM OF INSTRUCTIONS AS TO USE OF EARGO, INC.’S RIGHTS CERTIFICATE Please consult Morrow Sodali LLC as to any questions at (800) 662-5200 and via email at [email protected]. The following instructions relate to a rights offering (the “Rights Offering”) by Eargo, Inc., a Delaware corporation (“Eargo”), to the holders of record of its common stock, $0.0001 par v |
|
| October 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| October 14, 2022 |
FWP 1 brhc10042938fwp.htm FWP Free Writing Prospectus Dated October 13, 2022 Filed Pursuant to Rule 433 Registration No. 333-267071 On October 13, 2022, Eargo, Inc. (“Eargo” or the “Company”) issued a press release announcing the record date of its proposed rights offering. The contents of the press release can be found below: EARGO ANNOUNCES RECORD DATE FOR PROPOSED RIGHTS OFFERING • Record Date |
|
| October 13, 2022 |
Certificate of Amendment to Amended and Restated Certificate of Incorporation Exhibit 3.1 CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF EARGO, INC. Eargo, Inc. (the ?Corporation?), a corporation organized and existing under and by virtue of the Delaware General Corporation Law, hereby certifies as follows: (a) The name of the Corporation is Eargo, Inc. and the date on which the original Certificate of Incorporation of the Corporation was f |
|
| October 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| October 13, 2022 |
EAR / Eargo Inc / Gilde Healthcare Holding B.V. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 4)* EARGO, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 270087109 (CUSIP number) Edwin de Graaf Cooperatieve Gil |
|
| October 13, 2022 |
EARGO ANNOUNCES RECORD DATE FOR PROPOSED RIGHTS OFFERING Exhibit 99.1 EARGO ANNOUNCES RECORD DATE FOR PROPOSED RIGHTS OFFERING ? Record Date established as October 24, 2022 ? To be a stockholder of record, investors are advised to own EAR stock by 4:00 p.m. Eastern Time on Thursday, October 20, 2022 to account for T (trade) +2 settlement timing SAN JOSE, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) ? Eargo, Inc. (?Eargo? or the ?Company?) (NASDAQ: EAR), a med |
|
| October 11, 2022 |
EAR / Eargo Inc / Gilde Healthcare Holding B.V. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 3)* EARGO, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 270087109 (CUSIP number) Edwin de Graaf Cooperatieve Gil |
|
| October 6, 2022 |
EAR / Eargo Inc / Gilde Healthcare Holding B.V. - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 2)* EARGO, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 270087109 (CUSIP number) Edwin de Graaf Cooperatieve Gilde Health |
|
| October 6, 2022 |
EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. The undersigned acknowledge that each is responsible for |
|
| October 4, 2022 |
FWP 1 ny20004737x22fwp.htm FWP Free Writing Prospectus Dated October 4, 2022 Filed Pursuant to Rule 433 Registration No. 333-267071 On October 4, 2022, Eargo, Inc. (“Eargo” or the “Company”) held an investor update conference call in connection with the proxy solicitation for Eargo’s 2022 Annual Meeting of Stockholders. A transcript of the investor conference call can be found below. Operator Good |
|
| October 4, 2022 |
Free Writing Prospectus Dated October 4, 2022 Filed Pursuant to Rule 433 Registration No. |
|
| October 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| October 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| October 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number |
|
| October 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 30, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Num |
|
| September 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 30, 2022 |
Exhibit 99.1 Eargo to Hold Investor Update Conference Call on October 4, 2022 Company to Discuss Recently Commenced Proxy Solicitation Campaign for the 2022 Annual Meeting of Stockholders and the Importance of Voting as Soon as Possible ? Conference Call to be held on Tuesday, October 4, 2022 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) ? VOTE now to ensure the Company can conduct its propos |
|
| September 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 28, 2022 |
FWP 1 ny20004737x16fwp.htm FWP Free Writing Prospectus Dated September 28, 2022 Filed Pursuant to Rule 433 Registration No. 333-267071 On September 28, 2022, Eargo, Inc. (“Eargo” or the “Company”) began posting the following advertisements on certain websites, including Google, Yahoo! Finance, MarketWatch, CNBC, Seeking Alpha, StockTwits, the Wall Street Journal and Investor’s Business Daily: On S |
|
| September 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 27, 2022 |
FWP 1 ny20004737x14fwp.htm FWP Free Writing Prospectus Dated September 27, 2022 Filed Pursuant to Rule 433 Registration No. 333-267071 On September 27, 2022, Eargo, Inc. (“Eargo” or the “Company”) began using a voice message recorded by Christian Gormsen, Eargo’s President and Chief Executive Officer, in proxy solicitation calls made to stockholders in connection with Eargo’s 2022 Annual Meeting o |
|
| September 26, 2022 |
A transcript of the above video can be viewed at the bottom of this email. Free Writing Prospectus Dated September 26, 2022 Filed Pursuant to Rule 433 Registration No. |
|
| September 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 20, 2022 |
Free Writing Prospectus Dated September 20, 2022 Filed Pursuant to Rule 433 Registration No. |
|
| September 20, 2022 |
Employee Frequently Asked Questions about the Proxy Solicitation Free Writing Prospectus Dated September 20, 2022 Filed Pursuant to Rule 433 Registration No. |
|
| September 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 19, 2022 |
Free Writing Prospectus Dated September 19, 2022 Filed Pursuant to Rule 433 Registration No. |
|
| September 13, 2022 |
DEF 14A 1 ny20004737x5def14a.htm DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the |
|
| September 7, 2022 |
Free Writing Prospectus Dated September 7, 2022 Filed Pursuant to Rule 433 Registration No. |
|
| September 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ?? Filed by a party other than the Registrant ?? Check the appropriate box: ? ? ? Preliminary Proxy Statement ? ? ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2 |
|
| August 26, 2022 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? ? ? Preliminary Proxy Statement ? ? ? Confidential, for Use of the Commission Only (as permitted b |
|
| August 25, 2022 |
Power of Attorney (included on signature page to the initial filing of this registration statement) Table of Contents As filed with the U.S. Securities and Exchange Commission on August 25, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Eargo, Inc. (Exact name of registrant as specified in its charter) Delaware 5047 27-3879805 (State or other jurisdiction of incorporation or organ |
|
| August 25, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Eargo, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common Stock, par |
|
| August 12, 2022 |
PRE 14A 1 ny20004737x1pre14a.htm PRE 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of th |
|
| August 8, 2022 |
Eargo Reports Second Quarter 2022 Financial Results Exhibit 99.1 Eargo Reports Second Quarter 2022 Financial Results Financing Update: ? Strengthened financial position with up to $125 million strategic investment from Patient Square Capital (the ?Note Transaction?); closed first tranche investment of $100 million senior secured convertible notes on June 28, 2022 ? Company intends to seek stockholder approval to increase number of authorized shares |
|
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39616 Eargo, Inc. |
|
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| July 5, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| July 5, 2022 |
Eargo Closes First Tranche Investment of $100 Million from Patient Square Capital Exhibit 99.1 Eargo Closes First Tranche Investment of $100 Million from Patient Square Capital SAN JOSE, Calif., July 5, 2022 ? Eargo, Inc. (Nasdaq: EAR) (the ?Company?), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it has completed the issuance of $100 million aggregate principal amount of senior secured convertible notes to Pat |
|
| June 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction (Commission (IRS Employer of incorporation) |
|
| June 27, 2022 |
Form of Indemnification Agreement. Exhibit 10.2 Certain confidential information contained in this document, marked by [***], has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant treats as private or confidential. INDEMNIFICATION AND ADVANCEMENT AGREEMENT This Indemnification and Advancement Agreement (?Agreement?) is made as of , |
|
| June 27, 2022 |
Exhibit 10.1 Execution Version Certain confidential information contained in this document, marked by [***], has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant treats as private or confidential. NOTE PURCHASE AGREEMENT This NOTE PURCHASE AGREEMENT, dated as of June 24, 2022 (as amended, restate |
|
| June 27, 2022 |
Board Observer Agreement, dated June 24, 2022, by and between Eargo, Inc. and PSC Echo LP. EX-10.3 4 d303073dex103.htm EX-10.3 Exhibit 10.3 Certain confidential information contained in this document, marked by [***], has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant treats as private or confidential. BOARD OBSERVER AGREEMENT THIS BOARD OBSERVER AGREEMENT, dated as of June 24, 2022 |
|
| June 27, 2022 |
EX-10.4 5 d303073dex104.htm EX-10.4 Exhibit 10.4 Certain confidential information contained in this document, marked by [***], has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant treats as private or confidential. EARGO, INC. INVESTOR RIGHTS AGREEMENT June 24, 2022 TABLE OF CONTENTS Page SECTION |
|
| June 27, 2022 |
EX-99.1 7 d303073dex991.htm EX-99.1 Exhibit 99.1 Eargo Strengthens Financial Position with up to $125 Million Strategic Investment from Patient Square Capital Company to Hold Conference Call and Webcast on June 27, 2022 at 8 a.m. Eastern Time SAN JOSE, Calif., June 27, 2022 (GLOBE NEWSWIRE) – Eargo, Inc. (Nasdaq: EAR) (the “Company”), a medical device company on a mission to improve the quality of |
|
| June 27, 2022 |
EX-10.5 6 d303073dex105.htm EX-10.5 Exhibit 10.5 Certain confidential information contained in this document, marked by [***], has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant treats as private or confidential. REGISTRATION RIGHTS AGREEMENT BY AND BETWEEN EARGO, INC. AND PSC ECHO, LP Dated as |
|
| May 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 31, 2022 |
Nasdaq Confirms Continued Listing of Eargo Stock Exhibit 99.1 Nasdaq Confirms Continued Listing of Eargo Stock SAN JOSE, Calif., May 31, 2022 ? Eargo, Inc. (Nasdaq: EAR) (the ?Company? or Eargo?), a medical device company on a mission to improve the quality of life of people with hearing loss, announced today that it received a letter from The Nasdaq Stock Market LLC (?Nasdaq?) dated May 26, 2022 informing Eargo that the Company?s filing delinqu |
|
| May 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39616 Eargo, Inc. |
|
| May 13, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39616 Eargo, Inc. |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 13, 2022 |
Exhibit 10.17 STANDARD FORM OFFICE LEASE This. Standard Form Office Lease (?Lease?), dated for reference purposes only as of JULY 31, 2021, is entered into by and between GZI First North 1, LLC, a Delaware limited liability company (?Landlord?), and Eargo, Inc., a Delaware corporation (?Tenant?). ARTICLE I BASIC LEASE PROVISIONS Each reference in this Lease to the ?Basic Lease Provisions? shall me |
|
| May 13, 2022 |
Exhibit 10.18 FIRST AMENDMENT TO LEASE GZI FIRST NORTH 1, LLC This First Amendment to Lease is made as of this 26th day of January, 2022, by and between GZI First North 1, LLC, a Delaware Limited Liability Company, (as Lessor/Landlord) and EARGO, INC., A DELAWARE CORPORATION (as Lessee/Tenant). RECITALS A. Lessor and Lessee entered into that certain STANDARD FORM OFFICE LEASE dated for reference p |
|
| May 13, 2022 |
Exhibit 10.1 STANDARD FORM OFFICE LEASE This. Standard Form Office Lease (?Lease?), dated for reference purposes only as of JULY 31, 2021, is entered into by and between GZI First North 1, LLC, a Delaware limited liability company (?Landlord?), and Eargo, Inc., a Delaware corporation (?Tenant?). ARTICLE I BASIC LEASE PROVISIONS Each reference in this Lease to the ?Basic Lease Provisions? shall mea |
|
| May 13, 2022 |
Exhibit 10.2 FIRST AMENDMENT TO LEASE GZI FIRST NORTH 1, LLC This First Amendment to Lease is made as of this 26th day of January, 2022, by and between GZI First North 1, LLC, a Delaware Limited Liability Company, (as Lessor/Landlord) and EARGO, INC., A DELAWARE CORPORATION (as Lessee/Tenant). RECITALS A. Lessor and Lessee entered into that certain STANDARD FORM OFFICE LEASE dated for reference pu |
|
| May 13, 2022 |
Exhibit 10.3 EARGO, INC. 2020 INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE Eargo, Inc., a Delaware corporation (the ?Company?), pursuant to its 2020 Incentive Award Plan, as amended from time to time (the ?Plan?), hereby grants to the holder listed below (the ?Participant?), an award of restricted stock units (?Restricted Stock Units? or ?RSUs?). Each vested Restricted Stock Unit |
|
| May 13, 2022 |
Eargo Announces Receipt of Nasdaq Non-Compliance Letter Exhibit 99.1 Eargo Announces Receipt of Nasdaq Non-Compliance Letter SAN JOSE, CA. May 13, 2022 ? Eargo, Inc. (Nasdaq: EAR) (the ?Company? or ?Eargo?), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the Company received a letter (the ?Letter?) from The Nasdaq Stock Market LLC (?Nasdaq?) notifying the Company that because it remains |
|
| May 13, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-396 |
|
| May 13, 2022 |
Exhibit 21.1 Subsidiaries of Eargo, Inc. The registrant?s subsidiaries and affiliates as of December 31, 2021 are included in the list below. Legal Name of Subsidiary Jurisdiction of Organization Eargo Hearing, Inc. California Eargo Screening, LLC Delaware |
|
| May 13, 2022 |
Exhibit 10.3(c) EARGO, INC. 2020 INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE Eargo, Inc., a Delaware corporation (the ?Company?), pursuant to its 2020 Incentive Award Plan, as amended from time to time (the ?Plan?), hereby grants to the holder listed below (the ?Participant?), an award of restricted stock units (?Restricted Stock Units? or ?RSUs?). Each vested Restricted Stock Un |
|
| May 13, 2022 |
Exhibit 10.16 FIRST AMENDMENT TO LEASE GZI FIRST NORTH 1, LLC This First Amendment to Lease is made as of this 26th day of January, 2022, by and between GZI First North 1, LLC, a Delaware Limited Liability Company, (as Lessor/Landlord) and EARGO, INC., A DELAWARE CORPORATION (as Lessee/Tenant). RECITALS A. Lessor and Lessee entered into that certain STANDARD FORM OFFICE LEASE dated for reference p |
|
| May 11, 2022 |
OMB APPROVAL OMB Number: 3235-0058 Expires April 30, 2022 Estimated average burden Hours per response 2. |
|
| May 2, 2022 |
Exhibit 99.1 Eargo Provides Business Update Reached settlement agreement to resolve DOJ investigation Company to Hold Conference Call and Web Cast on May 2, 2022 at 8:00 a.m. Eastern Time SAN JOSE, CA., April 29, 2022 ? Eargo, Inc. (Nasdaq: EAR) (the ?Company?), a medical device company on a mission to improve the quality of life of people with hearing loss, today provided a business update and pr |
|
| May 2, 2022 |
Exhibit 99.2 Eargo Finalizes Agreement with the United States to Resolve Investigation With No Admission of Liability SAN JOSE, CA., April 29, 2022 ? Eargo, Inc. (Nasdaq: EAR) (?Eargo? or the ?Company?) has entered into a civil settlement agreement with the United States to resolve the previously disclosed investigation by the U.S. Department of Justice (the ?DOJ?) related to insurance reimburseme |
|
| May 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 2, 2022 |
Exhibit 10.1 SETTLEMENT AGREEMENT This Settlement Agreement (?Agreement?) is entered into among the United States of America, acting through the United States Department of Justice, and on behalf of the Office of Personnel Management (?OPM?), which administers the Federal Employees Health Benefits Program (?FEHBP?) (collectively, the ?United States?), and Eargo, Inc. (?Eargo? or the ?Company?) (he |
|
| March 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| March 10, 2022 |
Eargo Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-K EX-99.1 2 brhc10035045ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Eargo Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-K SAN JOSE, CA. March 10, 2022 – Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the Company received a letter from the Listing Qualifica |
|
| March 2, 2022 |
OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response 2. |
|
| February 11, 2022 |
EX-99.1 2 tm226298d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JOINT FILING AGREEMENT This joint filing agreement (this “Agreement”), is made and entered into as of February 10, 2021, by and between Future Fund Board of Guardians (“FFBG”) and Future Fund Investment Company No.4 Pty Ltd (ACN 134 338 908) (“FF” and together with FFBG, the “FF Parties”). The FF Parties hereby acknowledge and agree that the |
|
| February 11, 2022 |
EAR / Eargo Inc / Future Fund Board of Guardians - SC 13G/A Passive Investment SC 13G/A 1 tm226298d1sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Eargo, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 270087109 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate |
|
| January 18, 2022 |
Promotion Letter, dated January 12, 2022, by and between Eargo, Inc. and Mark Thorpe. Exhibit 10.1 January 12, 2022 Mark Thorpe (sent via DocuSign) Dear Mark: On behalf of Eargo, Inc., (the ?Company?), and following the approval of the Company?s Board of Directors, we are pleased to offer you a new position within the Company as Chief Accounting Officer (CAO), effective January 16, 2022. The details and terms associated with the new position are listed below: Job Title: Chief Accou |
|
| January 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| January 18, 2022 |
Employment Agreement, dated January 16, 2022, by and between Eargo, Inc. and Mark Thorpe. EX-10.2 3 brhc10032856ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 EARGO, INC. EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”), entered into effective as of January 16, 2022 (the “Effective Date”), is between Eargo, Inc., a Delaware corporation (the “Company”) and Mark Thorpe (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certai |
|
| January 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2022 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number |
|
| December 7, 2021 |
Costs Associated with Exit or Disposal Activities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2021 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| November 22, 2021 |
Eargo Receives Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q EX-99.1 2 d255968dex991.htm EX-99.1 Exhibit 99.1 Eargo Receives Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q SAN JOSE, CA. November 22, 2021 – Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the Company received a letter from The Nasdaq Stock Market L |
|
| November 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2021 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| November 16, 2021 |
OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response 2. |
|
| November 12, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2021 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| September 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 24, 2021 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? ? ? Preliminary Proxy Statement ? ? ? Confidential, for Use of the Commission Only (as permitted by |
|
| September 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2021 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Num |
|
| September 10, 2021 |
EAR / Eargo Inc / ALGER ASSOCIATES INC - EARGO, INC. Passive Investment SC 13G/A 1 d181133dsc13ga.htm EARGO, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Eargo, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 270087109 (CUSIP Number) August 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| September 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2021 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39616 Eargo, Inc. |
|
| August 12, 2021 |
Exhibit 99.1 Eargo Reports Second Quarter 2021 Financial Results Increases Full Year Net Revenue Guidance to Between $93 Million and $96 Million Second Quarter 2021 Highlights: ? Net revenues of $22.9 million, up 43.7% year-over-year ? Gross systems shipped of 12,548, up 38.8% year-over-year ? Return accrual rate of 24.1%, a 3.0 percentage point improvement year-over-year ? GAAP gross margin of 71 |
|
| August 12, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2021 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number |
|
| August 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2021 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 10, 2021 |
EAR / Eargo Inc / ALGER ASSOCIATES INC - EARGO, INC. Passive Investment Eargo, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Eargo, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 270087109 (CUSIP Number) May 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| June 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2021 (June 9, 2021) EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commissio |
|
| June 10, 2021 |
EX-99.1 2 d180882dex991.htm EX-99.1 Exhibit 99.1 Eargo Appoints Katie Bayne to Board of Directors 28-year Coca-Cola Executive and Global Brand Builder Joins Effective June 9, 2021 SAN JOSE, CA. June 10, 2021 – Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the appointment of Katie Bayne to its Board of Di |
|
| June 3, 2021 |
Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Eargo, Inc. (Name of Issuer) Common Stock, $.0001 par value (Title of Class of Securities) 270087109 (CUSIP Number) Louis S. Citron, Esq. New Enterprise Associates 1954 Greenspring Drive, Suite 600, Timonium, MD 21093 (410) 842-4000 (Name, A |
|
| May 27, 2021 |
EAR / Eargo Inc / Longitude Capital Partners IV, LLC - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) EARGO, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 270087109 (CUSIP Number) Patrick G. Enright Managing Member Longitude Capital Partners IV, LLC 2740 Sand Hill Road, 2nd Floor Menlo Park, CA 94025 (650) 854-5700 (Name |
|
| May 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39616 Eargo, Inc. |
|
| May 13, 2021 |
Exhibit 10.1 FIRST AMENDMENT TO LEASE THIS FIRST AMENDMENT made and entered into this 19th day of February 2021, by and between SEV 8th and Division a Tennessee Limited Liability Company (hereinafter referred to as ?Landlord?) and Eargo, Inc. a Delaware Corporation (hereinafter referred to as ?Tenant?). W I T N E S S E T H: WHEREAS, Landlord and Tenant entered into a Lease dated September 11, 2018 |
|
| May 12, 2021 |
Eargo Reports First Quarter 2021 Financial Results EX-99.1 2 d17217dex991.htm EX-99.1 Exhibit 99.1 Eargo Reports First Quarter 2021 Financial Results Recent Highlights: • Net revenues of $22.0 million, up 74.0% year-over-year • Gross systems shipped of 11,704, up 66.5% year-over-year • Return accrual rate of 23.2%, a 4.4 percentage point improvement year-over-year • GAAP gross margin of 71.4%, up 8.2 percentage points year-over-year; non-GAAP gros |
|
| May 12, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2021 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| April 28, 2021 |
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 1)* EARGO, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 270087109 (CUSIP number) M.O.J.M. Perret Cooperatieve Gi |
|
| April 28, 2021 |
EX-99.1 2 d167597dex991.htm EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. The undersigned acknowledge t |
|
| April 26, 2021 |
SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) EARGO, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 270087109 (CUSIP Number) Patrick G. Enright Managing Member Longitude Capital Partners IV, LLC 2740 Sand Hill Road, 2nd Floor Menlo Park, CA 94025 (650) 854-5 |
|
| March 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39616 Eargo, Inc. (Ex |
|
| March 16, 2021 |
As filed with the Securities and Exchange Commission on March 16, 2021 Registration No. |
|
| March 16, 2021 |
Exhibit 4.3 DESCRIPTION OF REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2020, Eargo, Inc. had common stock, $0.0001 par value per share, registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?), and listed on the Nasdaq Global Select Market under the trading symbol ?EAR.? DESCRIPTION O |
|
| February 25, 2021 |
EX-99.1 Exhibit 99.1 Eargo Reports Fourth Quarter and Full Year 2020 Financial Results Provides Full Year 2021 Financial Guidance Recent Highlights: • Net revenues of $22.4 million in the fourth quarter and $69.2 million for the full year of 2020, representing 110.8% and 110.9% increases, respectively, over the corresponding periods of 2019 • Gross systems shipped of 12,096 in the fourth quarter a |
|
| February 25, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2021 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| February 11, 2021 |
EX-99.1 2 tm216162d2ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JOINT FILING AGREEMENT This joint filing agreement (this “Agreement”), is made and entered into as of February 10, 2021, by and between Future Fund Board of Guardians (“FFBG”) and Future Fund Investment Company No.4 Pty Ltd (ACN 134 338 908) (“FF” and together with FFBG, the “FF Parties”). The FF Parties hereby acknowledge and agree that the |
|
| February 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Eargo, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 270087109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| January 11, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d55640d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2021 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorpor |
|
| January 11, 2021 |
EX-99.1 Exhibit 99.1 Eargo Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Net Revenue and Preliminary Gross Systems Shipped SAN JOSE, CA. January 11, 2021 – Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced its preliminary unaudited net revenue and preliminary gross systems shipped for the |
|
| November 20, 2020 |
Eargo Reports Third Quarter 2020 Financial Results EX-99.1 Exhibit 99.1 Eargo Reports Third Quarter 2020 Financial Results Third Quarter and Recent Highlights: • Net revenues of $18.2 million, up 135.3% year-over-year • Gross systems shipped of 10,077, up 91.7% year-over-year • Return accrual rate of 25.2%, a 10.1 percentage point improvement year-over-year • Gross margin of 70.1%, up 16.5 percentage points year-over-year • Sales and marketing exp |
|
| November 20, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39616 Eargo, Inc. |
|
| November 20, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2020 EARGO, INC. (Exact name of registrant as specified in its charter) Delaware 001-39616 27-3879804 (State or other jurisdiction of incorporation) (Commission File |
|
| October 30, 2020 |
EX-99.1 Exhibit 1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. The undersigned acknowledge that each is responsible for the |
